Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21559334 | 0.98 | ALDH1A1 (0.32) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL19151966 | 0.96 | MAPT (0.34) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL25145480 | 0.96 | MAPT (0.34) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL16996037 | 0.94 | MAPT (0.31) | MAPTSMN1; SMN2ALDH1A1KDM4EMEN1 | |
| SCHEMBL10038994 | 0.93 | ALDH1A1 (0.35) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL20466627 | 0.93 | MAPT (0.37) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL22403641 | 0.93 | PDK2 (0.30) | PDK2 | |
| SCHEMBL25563034 | 0.92 | ALDH1A1 (0.33) | MAPTSMN1; SMN2ALDH1A1HPGDRAB9A | |
| SCHEMBL24882965 | 0.92 | ESR1 (0.35) | MAPTSMN1; SMN2KDM4EMEN1LMNA | |
| SCHEMBL21559422 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-11744145-B2 | Organic compound and organic electroluminescent device comprising the same | LG DISPLAY CO., LTD. (KR) | 2023-08-29 | — | — | US | disclosed |
| US-20230146354-A1 | LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230146354-A1 | LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-11 | — | — | US | disclosed |
| US-20230124044-A1 | LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-04-20 | — | — | US | disclosed |
| US-20190296238-A1 | Organic Light-emitting Element | LG CHEM, LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296238-A1 | Organic Light-emitting Element | CRY1, CRY2, NR2E3 | MAPT 665/4885SMN1; SMN2 2267/4885ALDH1A1 567/4885 |
| US-11877509-B2 | Organic light-emitting element | CRY1, CRY2, NR2E3 | MAPT 665/4885SMN1; SMN2 2267/4885ALDH1A1 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.